Skip to search.
 BSE Up0.15% NSE Up0.28%

More On ALBERTDA.BO

Quotes

Charts

News & Info

  • Headlines
  • Company Events

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Albert David Ltd. (ALBERTDA.BO)

-BSE

89.00 Up 0.60(0.68%) 24 May 3:15PM

Add to Portfolio
ProfileGet Profile for:
Albert David Ltd.
15, Chittaranjan Avenue
Kolkata, 700072
India - Map
Phone: 91 33 2212 9700
Fax: 91 33 2225 8714
Website: http://www.albertdavidindia.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Major
Full Time Employees:N/A

Business Summary 

Albert David Limited operates as a pharmaceutical company primarily in India. The company manufactures pharmaceutical formulations and bulk drugs, infusion solutions and oral solids, and disposable syringes and needles. It operates in various therapeutic segments, including analgesics/anti inflammatory/antipyretics, anti-bacterials/anti-protozoals, antiĀ–ulcerants, dermatologicals, small and large volume parenterals, disposable syringes and needles/blood I.V. sets, ayurvedic formulations, nutrition/vitamins, haematinics, cough preparations, anthelmintic, haemostatic, laxatives, skeletal relaxants, anti-arthiritic/chondroprotective agents, and nimeril-MD mouth dissolving tablets, as well as actibile, a non-toxic hydrophilic bile acid. The company exports its products primarily to Vietnam, Russia, Belarus, Egypt, Bangladesh, Kenya, Tanzania, Uganda, Sudan, Ethiopia, Nigeria, Zaire, Haiti, Brazil, Canada, the United States, the United Kingdom, the Netherlands, and Germany. Albert David Limited distributes its products primarily through stockistsĀ’ outlets and sales depots. The company was incorporated in 1938 and is headquartered in Kolkata, India.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Albert David Ltd.

Key Executives 
 PayExercised
Mr. Arun Kumar Kothari , 60
Chairman, Managing Director, Member of Share Transfer/Shareholders/Investors Grievance Committee, Member of Remuneration Committee and Member of Audit Committee
5.24MN/A
Sri. K. P. Mundhra M.Sc.(Hons.), 69
Exec. Director and Member of Share Transfer/Shareholders/Investors Grievance Committee
6.16MN/A
Shri. S. C. Shah ,
Chief Financial Officer and VP of Fin.
N/AN/A
Dr. D. P. Ghosh ,
Corp. Head of Technical & Scientific Devel.
N/AN/A
Shri. Indrajit Dhar ,
Compliance Officer and Company Sec.
N/AN/A
Amounts are as of 31-Dec-2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in INR.